TransMedics Cash Conversion Cycle from 2010 to 2025

TMDX Stock  USD 73.76  0.76  1.04%   
TransMedics Cash Conversion Cycle yearly trend continues to be fairly stable with very little volatility. Cash Conversion Cycle is likely to outpace its year average in 2025. During the period from 2010 to 2025, TransMedics Cash Conversion Cycle regression line of annual values had r-squared of  0.06 and arithmetic mean of  304.73. View All Fundamentals
 
Cash Conversion Cycle  
First Reported
2010-12-31
Previous Quarter
204.72
Current Value
262.5
Quarterly Volatility
102.59373731
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check TransMedics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among TransMedics' main balance sheet or income statement drivers, such as Interest Expense of 13 M, Selling General Administrative of 144.4 M or Research Development of 76.4 M, as well as many indicators such as Price To Sales Ratio of 11.6, Dividend Yield of 0.0 or PTB Ratio of 17.68. TransMedics financial statements analysis is a perfect complement when working with TransMedics Valuation or Volatility modules.
  
Check out the analysis of TransMedics Correlation against competitors.

Latest TransMedics' Cash Conversion Cycle Growth Pattern

Below is the plot of the Cash Conversion Cycle of TransMedics Group over the last few years. It is TransMedics' Cash Conversion Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in TransMedics' overall financial position and show how it may be relating to other accounts over time.
Cash Conversion Cycle10 Years Trend
Pretty Stable
   Cash Conversion Cycle   
       Timeline  

TransMedics Cash Conversion Cycle Regression Statistics

Arithmetic Mean304.73
Geometric Mean291.57
Coefficient Of Variation33.67
Mean Deviation78.85
Median250.15
Standard Deviation102.59
Sample Variance10,525
Range328
R-Value0.24
Mean Square Error10,647
R-Squared0.06
Significance0.38
Slope5.10
Total Sum of Squares157,882

TransMedics Cash Conversion Cycle History

2025 262.5
2024 204.72
2023 227.47
2022 331.39
2021 400.69
2019 532.6
2018 324.78

About TransMedics Financial Statements

TransMedics investors use historical fundamental indicators, such as TransMedics' Cash Conversion Cycle, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in TransMedics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cash Conversion Cycle 204.72  262.50 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for TransMedics Stock Analysis

When running TransMedics' price analysis, check to measure TransMedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TransMedics is operating at the current time. Most of TransMedics' value examination focuses on studying past and present price action to predict the probability of TransMedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TransMedics' price. Additionally, you may evaluate how the addition of TransMedics to your portfolios can decrease your overall portfolio volatility.